RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Bexley, OH · Canal Winchester, OH · Canton, OH · +119 more sites
2 recruiting psoriasis studies with a site in Mason, OH.
Sponsor: Bristol-Myers Squibb
Bexley, OH · Canal Winchester, OH · Canton, OH · +119 more sites
Sponsor: Oruka Therapeutics, Inc.
Mason, OH · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.